Greg Dillon, founder and president of Lower Fifth Psychiatric in New York City and an assistant professor of psychiatry and public health at the Weill Cornell Medical College and New York Presbyterian Hospital Cornell, explained that it is essential for us to think of what there is to gain and lose from taking GLP-1 drugs
Specifically, the participants who received semaglutide had greater free thyroxine (FT4) levels and a greater decrease in thyroid-stimulating hormone (TSH) levels compared to the placebo group
Compounded Semaglutide GLP-1 , a medication originally developed for managing type 2 diabetes, has recently gained attention for its potential benefits in weight loss
Nauck MA, Quast DR, Wefers J, Meier JJ
Wegovy is not suitable for all patients
Possible Side Effects: Nausea, constipation, and stomach discomfort are commonespecially in the early weeks